Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Gentamicin vs Oral Nitrofurantoin for Acute UTI
NCT03299387Phase 4Withdrawn
- Sponsor
- Mayo Clinic
- Start
- Jun 2017
- Primary completion
- Jul 2018
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
01
Overview
Phase 4, randomised, open-label trial of gentamicin in urinary tract infection (UTI) (2 arms), sponsored by Mayo Clinic. Primary endpoints: Change in microbiologic effect of a chronic acute Urinary Tract Infection and Change in symptomatic relief of a chronic acute Urinary Tract Infection. Planned start Jun 2017; status: withdrawn.
02
Drugs
gentamicin
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on NCT03299387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03299387.